<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00789269</url>
  </required_header>
  <id_info>
    <org_study_id>rhubarb ischemia</org_study_id>
    <nct_id>NCT00789269</nct_id>
  </id_info>
  <brief_title>Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From a Stroke</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <brief_summary>
    <textblock>
      This study will determine if rhubarb will reduced the incidence of pneumonia and improved&#xD;
      recovery from an acute stroke. The study is designed to look at both infection rate and&#xD;
      overall recovery and recovery of motor function, for example muscle strength and&#xD;
      coordination.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The lung infection rate within 14 days after stroke onset</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global disability on modified Rankin scale</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIH stroke scale</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barthel Index</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death rate</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Syndrome score by Traditional Chinese Medicine (TCM) standard</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in laboratory indexes as safety assessment, including red blood cell(RBC), white blood cell(WBC), platelet(PLT), alanine transaminase (ALT), aspartate transaminase (AST), blood urea nitrogen (BUN), creatinine(Cr) in blood samples, etc.</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pneumonia</condition>
  <condition>Acute Stroke</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rhubarb</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rhubarb</intervention_name>
    <description>14 days of rhubarb</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>14 days of placebo</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Occurrence of an acute ischemic stroke (between 9 and 72 h after onset) with a score&#xD;
             of at least 6 on the National Institute of Health Stroke Scale (NIHSS), and patient&#xD;
             age of at least 18 years.&#xD;
&#xD;
          -  Have no pneumonia according to modified criteria of the U.S. Centers for Disease&#xD;
             Control and Prevention (CDC)&#xD;
&#xD;
          -  Consistent with the Constipation of Phlegm-Heat Accumulation type by Traditional&#xD;
             Chinese Medicine (TCM) standard&#xD;
&#xD;
          -  Patients or their representatives voluntarily take part in this study and signed the&#xD;
             informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cerebral hemorrhage, subarachnoid hemorrhage&#xD;
&#xD;
          -  Transient ischemic attack(TIA)&#xD;
&#xD;
          -  Proven cerebral embolism caused by tumor, Brain Trauma, cerebral parasitic disease,&#xD;
             dysbolismus, fibrillation atrial resulted from rheumatic heart disease, coronary heart&#xD;
             disease, and other heart diseases&#xD;
&#xD;
          -  Clinical signs of infection on admission&#xD;
&#xD;
          -  Pregnant or breast-feeding&#xD;
&#xD;
          -  Allergic to rhubarb&#xD;
&#xD;
          -  Preceding or ongoing antibiotic therapy within the last 24 h&#xD;
&#xD;
          -  Participation in another interventional trial&#xD;
&#xD;
          -  Immunosuppressant treatment within the last 30 days&#xD;
&#xD;
          -  Combining severe clinical conditions such as liver, kidney, Hematopoietic System,&#xD;
             endocrine system or psychological diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Integrative Medicine, Zhongshan hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <study_first_submitted>November 10, 2008</study_first_submitted>
  <study_first_submitted_qc>November 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2008</study_first_posted>
  <last_update_submitted>May 26, 2010</last_update_submitted>
  <last_update_submitted_qc>May 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Zhongshan hospital, Fudan University</name_title>
    <organization>TCM department, Zhongshan hospital, Fudan University</organization>
  </responsible_party>
  <keyword>lung infection after ischemic Stroke</keyword>
  <keyword>prevention of pneumonia</keyword>
  <keyword>rhubarb</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

